Viewing StudyNCT05283109



Ignite Creation Date: 2024-05-06 @ 5:22 PM
Last Modification Date: 2024-10-26 @ 2:27 PM
Study NCT ID: NCT05283109
Status: RECRUITING
Last Update Posted: 2023-09-08
First Post: 2022-03-08

Brief Title: ETAPA I Peptide-based Tumor Associated Antigen Vaccine in GBM
Sponsor: Mustafa Khasraw MBChB MD FRCP FRACP
Organization: Duke University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-08-30
Start Date Type: ACTUAL
Primary Completion Date: 2025-04
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-02
Completion Date Type: ESTIMATED
First Submit Date: 2022-03-08
First Submit QC Date: March 8 2022
Study First Post Date: 2022-03-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-21
Last Update Post Date: 2023-09-08
Last Update Post Date Type: ACTUAL